Biodexa Pharmaceuticals (BDRX)
undefined
undefined%
At close: undefined
4.20
-1.18%
After-hours Dec 13, 2024, 04:02 PM EST

Biodexa Pharmaceuticals Forcast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for BDRX stock have an median target of 200, with a low estimate of 200 and a high estimate of 200. The median target predicts an increase of 4605.88% from the current stock price of 4.25.

Analyst Consensus: Buy
Target Low Average Median High
Price $200 $200 $200 $200
Change 4605.88% 4605.88% 4605.88% 4605.88%

AI Analyst Report

According to 1 stock analyst, the rating for Biodexa Pharmaceuticals is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Feb 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
26.02K
from 381.00K
Increased by -93.2%
Revenue Next Year
13.06K
from 26.02K
Increased by -49.8%
EPS This Year
-0.03
from -8.97
Increased by 99.7%
EPS Next Year
-0.02
from -0.03
Increased by 33.3%